© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Back in the late 1970s, infectious disease wards saw a new face in the fight against bacteria—Cefoperazone. Developed at a time when resistant Gram-negative bacteria like Pseudomonas aeruginosa threatened to outmaneuver earlier antibiotics, chemists saw promise in tweaking the basic cephalosporin skeleton. These early years often meant months spent in the lab, with researchers manually isolating the right betas and trying different sodium salts for stability. As bacterial resistance patterns shifted, so did the drive behind drug development. Experience from clinicians shaped the formulation and combination with other agents, enriching the understanding of the pharmacokinetics, and setting a bar for hospital antibiotic stewardship programs that we lean on even now.
Cefoperazone Sodium stands out as a third-generation cephalosporin, meaning it's built to handle more stubborn hospital bugs. In practice, the sodium salt keeps things water-soluble, allowing straightforward intravenous and intramuscular dosing. Hospital pharmacies depend on its broad-spectrum activity, especially in cases of sepsis, complicated urinary tract infections, and intra-abdominal disasters. It often shows up in vials as a sterile, off-white powder, meant for immediate reconstitution ahead of administration. Doctors pay attention to the dosing regimens because this drug clears predominantly through the biliary tract, not through the kidneys like many other beta-lactams. That’s handy for patients with tricky renal profiles but often requires calibration in those with liver conditions.
With a molecular formula of C25H26N9NaO8S2, this antibiotic appears as a pale yellow or almost white crystalline powder. It's hygroscopic, so bottles must stay sealed against humidity until use. Cefoperazone Sodium dissolves easily in water, which aids bedside preparation. From a chemistry perspective, that 3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl] group on the side chain gives a hint why it manages such broad activity against Gram-negative bacteria. Physical stability depends significantly on pH; the drug solution quickly loses potency in alkaline settings. That’s a practical point for nurses mixing infusions, less so for lab work, but it marks a key distinction from other cephalosporins.
Most formulations get packed with a label marking the dosage in grams, commonly 1g or 2g per vial. Each vial points out if excipients appear in the mix, such as sodium carbonate, and gives strict directions for reconstitution. Regulatory agencies, like the FDA and EMA, keep tight reins, demanding batch testing down to traces of degradation products and accurate impurity profiles. Given the risks of confusion in busy wards, color-coded caps and clear expiry dates carry real-life importance, not just regulatory significance. Safety information warns about the dangers of mixing this drug with certain infusion fluids, notably calcium-containing solutions—a point hammered into the daily routines of pharmacy staff.
Cefoperazone Sodium doesn’t spring from a one-pot reaction. Production draws from fermentation using select semi-synthetic cephalosporin intermediates, then involves protection and deprotection of the beta-lactam ring—a sensitive structure destroyed by both acid and base if handled roughly. Once core synthesis wraps, the final step involves sodium addition, which ensures quick dissolution in hospital settings. Rigorous purification follows, and product crystallinity gets checked microscopically to ensure consistent dosing. Toward the finishing stages, careful vacuum drying avoids destabilizing the molecule through heat exposure, a mistake learned the hard way during earlier decades’ manufacturing mishaps.
Chemists tried to extend action against resistant bacteria by modifying side chains. Insights from beta-lactamase resistance led to tweaks in the tetrazole moiety—engineered to dodge common beta-lactamases found in certain E. coli and Pseudomonas strains. Though the core bicyclic structure remains classic cephalosporin, these subtle chemical inventions keep Cefoperazone active where older agents lost ground. The compound responds poorly to highly alkaline environments, easily breaking its beta-lactam ring and losing efficacy. Combining Cefoperazone Sodium with the beta-lactamase inhibitor sulbactam marked another milestone, conferring resistance-breaking attributes and broadening its application to problem settings in ICUs worldwide.
Medical professionals know Cefoperazone Sodium under several labels: Cefobid, Cefoperazon, and names that update slightly across regulatory zones. The compound’s INN (international nonproprietary name) stays constant, while local branding and generics multiply in markets from North America to Southeast Asia. Hospitals running their procurement programs keep a list of these alternate names, given supply chain headaches from manufacturer changes or sudden recalls.
Proper handling in pharmacy settings can’t be downplayed. Direct contact with the powder should get avoided; some people develop allergic skin reactions. Reconstituted solutions need prompt use, as shelf life runs short. Nurses learn early that this antibiotic doesn’t mix with calcium-containing IV solutions because of risk for precipitation forming dangerous emboli—an error that showed up in adverse event reports a decade ago. Healthcare staff keep resuscitation equipment close by during first injections in case of anaphylaxis, and protocols demand double-checking for possible prior cephalosporin or penicillin allergies.
Cefoperazone Sodium covers a swath of life-threatening bacterial infections that stump other agents. In my own hospital experience, infectious disease specialists turn to it in situations with mixed infections—especially abdominal sepsis, nosocomial pneumonia, and joint infections following orthopedic surgery. The biliary excretion route allows use in complicated gallbladder disease, where other antibiotics struggle. Pediatric ICU teams rely on it in pediatric sepsis cases, but only after screening for liver function since that remains a unique aspect of the drug’s kinetic profile. Outside hospitals, use remains limited since oral formulations never proved viable and outpatient therapy demands easier administration schedules.
Labs worldwide push the envelope exploring new cefoperazone-based derivatives to tackle rising drug resistance. Big data on bacterial genomics now shapes early choices in chemical design, reducing trial-and-error but raising costs. Some research links focus squarely on optimizing combination therapy, pairing the drug with novel beta-lactamase inhibitors to counter multidrug-resistant Gram-negatives found in hospital outbreaks. Others examine the role of sub-inhibitory concentrations in fostering resistance, prompting calls for tighter stewardship and sophisticated dosing protocols. Investment in R&D remains high, thanks to grants from agencies worried about the post-antibiotic era, but results show that nature always stays a step ahead in the arms race.
Long-term animal studies and patient data both spell out Cefoperazone Sodium’s safety boundaries. Neurotoxicity concerns rise at high doses, particularly when kidney or liver impairment extends drug levels in the body. In rare cases, serious side effects include coagulopathy, sometimes shifting clotting times and raising bleeding risk, especially in critical care settings. Research flags special caution where hypoprothrombinemia coincides with malnourished patients or prolonged use. Routine monitoring for liver function, coagulation status, and allergic response forms the backbone of safe administration. Cases of superinfection, like secondary Clostridioides difficile colitis, often underline the importance of vigilant prescribing and rapid recognition of unexpected adverse reactions.
As resistant organisms grow smarter, Cefoperazone Sodium’s formula faces renewed scrutiny. Pharmaceutical companies pour resources into exploring next-generation modifications, some harnessing new delivery vehicles like nanoparticles. AI-driven screening for more potent analogs seeks to outpace evolving resistance genes. On the practical front, rapid diagnostics drive tailored therapy, opening opportunities for targeted use of the drug rather than broad application. Combination regimens could extend the antibiotic’s useful life in human medicine. There’s rising chatter about combining it with immunotherapies in experimental settings. The big picture points to a future where old workhorse antibiotics like Cefoperazone Sodium gain fresh relevance, but only through tight coordination across research, regulation, and bedside practice.
If you’ve landed in a hospital with a high fever or a serious infection, chances are a healthcare worker might reach for cefoperazone sodium. This isn’t the kind of drug folks keep at home or buy for common colds. Hospitals keep it for people fighting strong infections that regular antibiotics just can’t tackle. You usually see it used for complicated cases like pneumonia, infections in the belly, urinary tract, skin, or even blood.
This drug belongs to the cephalosporin family, the same group doctors trust when the stakes are high and time is tight. Cefoperazone steps in against “gram-negative” bacteria – think of tough germs like Pseudomonas aeruginosa, Klebsiella, and Escherichia coli. These germs set up camp in places like hospitals and can make patients already fighting other problems much sicker. They resist penicillin and weaker antibiotics. In these cases, using the right tool for the job stops the infection from spreading or getting worse.
Not all antibiotics work for every infection. Overusing certain antibiotics, or using the wrong one, gives germs new tricks for fighting back—that’s how resistance spreads. Cefoperazone sodium only gets handed out after someone figures out the type of bacteria involved. Labs run tests on your blood, urine, or wound. If those tests point to bacteria that respond to cefoperazone, doctors pick it. They don’t throw it at just any cough or sore throat.
You won’t find this one as a pill at the pharmacy. Hospitals give cefoperazone as an injection or in a drip straight into the veins. This helps it reach infected organs fast and in big enough amounts. Getting the dose right matters. It depends on your age, weight, kidney or liver function. Folks with weak kidneys or livers need careful monitoring—what’s helpful for one person can overwhelm another.
This drug, like every medicine, has a risk of side effects. Some people get rashes or upset stomachs. The risk of diarrhea goes up, especially when powerful antibiotics take out helpful bacteria in the gut alongside the bad ones. More rarely, allergic reactions pop up, especially in people with allergies to penicillin or related drugs. Doctors always weigh these risks against what could happen if the infection spreads unchecked.
Doctor friends I know always stress that medicine like cefoperazone sodium belongs on the “only when needed” shelf. The world keeps seeing more drug-resistant bacteria. Using these big-gun antibiotics only when essential helps make sure they stay effective for those who need them most. That’s why hospitals routinely review their infection policies and keep a close eye on resistant bacteria patterns in their area.
Infections thrive where hygiene lapses. Handwashing, cleaning hospital equipment, and isolating contagious patients lighten the load on antibiotics like cefoperazone sodium. Education for health workers about choosing antibiotics wisely goes just as far. Patients can play their part by finishing prescribed courses and not pressuring doctors for antibiotics for every mild illness.
Growing up, I watched physicians trade stories about tough infections that didn’t budge with standard antibiotics. The phrase “give it IV” would show up like a secret weapon when someone brought up Cefoperazone Sodium. Even now, practitioners still argue over the best ways to administer antibiotics, because the way they go in can impact everything from side effects to patient survival.
Unlike antibiotics you take by mouth, Cefoperazone Sodium heads straight for the bloodstream. This drug is made for intravenous (IV) or intramuscular (IM) injection. There's a reason doctors turn to these routes: infections getting out of hand need fast, concentrated doses. Swallow a pill, and the body’s filters in the gut and liver break some of it down before it even hits the target. With IV or IM routes, the full punch of antibiotic reaches the site of infection, offering better odds against severe bugs.
Allergic reactions, severe diarrhea, and shifting kidney function can pop up when using powerful antibiotics. Nurses and pharmacists check kidney status, look into allergies, and watch closely for reactions. Hospitals use protocols built by infectious disease specialists, recognizing that a tailored plan is the only way to keep this treatment both safe and effective. Knowing a doctor triple-checks your allergy to penicillin before giving an injection makes a difference.
Oral administration makes life easier but not safer in every case. Cefoperazone Sodium simply isn’t absorbed well through the digestive system. In my experience—seeing patients in both rural clinics and big city hospitals—when time counts, injections cut out the guesswork. That becomes especially important for people battling pneumonia, bloodstream infections, or complicated abdominal wounds. IV and IM delivery put the right dose where it counts, with a precision pills can’t match in these situations.
Not everyone lives near a well-stocked hospital. In remote areas, rural clinics sometimes lack full-time nurses trained in IV work. A cousin running a clinic on the outskirts of town described hauling supplies by motorbike and wishing oral options worked as well—“nobody loves an injection.” There’s a clear need to improve medical training, keeping rural teams ready for severe infections.
Cefoperazone Sodium also raises concerns about overuse. When doctors hand it out for minor infections—just to be on the safe side—antibiotic resistance creeps in. In my own training, I watched teams debate which bug we were really treating and found that clear protocols keep the big guns in reserve until confirmed infection strikes. Hospitals should keep education ongoing, so each new nurse or doctor understands not just how to administer injections, but why choosing a powerful antibiotic isn’t a decision to take lightly.
For now, Cefoperazone Sodium will stay in the hands of those who know how to inject safely. Training, thoughtful diagnosis, and clear communication with patients form the foundation of good use. Hospitals further benefit by supporting continued education and maintaining strong pharmacy support. When sick patients need complicated care, getting the route of administration right often draws the line between moving on to recovery or facing complications.
Cefoperazone Sodium fights off tough bacterial infections. Many people see relief with it, especially those in the hospital setting. But real-world use tells us you might hit a few bumps when starting this drug.
Change in digestion stands out as the side effect patients bring up most. Loose stools or even outright diarrhea tend to show up within days of the first dose. The gut’s natural bacteria don’t always fare well during a course of cefoperazone sodium. For some, the diarrhea is mild, but others deal with uncomfortable cramping and urgency. Sometimes, good bacteria in the intestines get thrown out of balance. That paves the path for Clostridioides difficile infection, known for causing tough cases of colitis. This isn’t some rare issue—recent studies put the chances close to 5-10% for hospitalized patients.
Anyone who’s experienced an antibiotic rash remembers the itching and redness. With cefoperazone sodium, this risk sits at a level similar to other cephalosporins. Red blotches or raised bumps can spread suddenly. Hives and swelling lurk as bigger threats, especially for those who’ve struggled with allergies in the past. When hives or swelling around the face and throat appear, you don’t wait to speak up. Immediate care becomes important, since that could be a sign of a life-threatening reaction called anaphylaxis.
Liver numbers in routine blood tests sometimes climb on cefoperazone sodium. I’ve seen people surprised when their doctor says they need to test liver function after starting this medicine. In the majority, these numbers settle down and don’t lead to any symptoms. But those with existing liver trouble—especially people with hepatitis or cirrhosis—need extra caution. A yellow tint to the skin or eyes signals something’s wrong and deserves quick action.
Some patients find unusual bruising or bleeding—maybe from the gums, maybe from the nose. Cefoperazone sodium sometimes interferes with vitamin K, the one that helps make sure blood clots normally. This risk isn’t as big in younger, healthy people, but anyone malnourished or with kidney or liver disease could see problems. Elderly people often take other medicines that also thin the blood, so their doctors have to keep a close watch, sometimes even topping up vitamin K just in case.
A few patients might mention headaches, a metallic taste, or feeling unsettled after a dose. Rare cases see chills or fever—usually the body’s response to killing off bacteria. Some folks deal with pain or swelling at the injection site, especially in hospital settings.
Side effects happen as part of the bargain when fighting infection. Open talk with your care team matters. The risk of side effects often weighs less than the risk from untreated infection, but everyone deserves to understand what to watch for. Staying well-hydrated, reporting anything strange, and not skipping routine bloodwork help avoid bigger complications.
Cefoperazone sodium usually comes up in the hospital setting as a broad-spectrum beta-lactam antibiotic, often used to fight off serious infections. It belongs to the cephalosporin family, which doctors trust for their ability to hit gram-negative bacteria hard. With more superbugs showing up, knowing who can and can’t safely get cefoperazone matters for patient safety and outcome.
A long day in the emergency department taught me the hard way that allergies matter. Anyone with a history of immediate allergic reactions to penicillins or cephalosporins should avoid cefoperazone. True allergic responses to these drugs can include rashes, swelling, trouble breathing, and even anaphylactic shock. It’s not just caution—exposing patients with known beta-lactam allergies may end fatally. Centers for Disease Control and Prevention estimates 10% of the US population reports penicillin allergy, though true allergy comes in lower when tested.
Cefoperazone also poses a problem for people with bleeding risks. This antibiotic can interfere with vitamin K metabolism in the liver. It blocks the pathways that keep the blood clotting system working right. Folks already on blood thinners, or those with underlying liver disease, run a much higher risk. Doctors often see nosesbleeds or unexplained bruising after a few days of therapy, and medical literature notes that severe bleeding may appear, especially if the liver isn’t healthy to start with.
Liver disease changes the game for many drugs, including cefoperazone. It relies on the liver for breakdown, and those with cirrhosis, hepatitis, or alcohol use disorder may find the drug building up to unsafe levels. High concentrations in the body can bring on more severe side effects—easy bruising or persistent diarrhea may end up being signs that point to the liver’s declining ability to do its job.
Alcohol gets its own warning label with cefoperazone. The medicine may cause a “disulfiram-like” reaction: facial flushing, nausea, pounding heart, low blood pressure, and sometimes collapse. Stories circulate among nurses and doctors about patients with even small amounts of alcohol in their system suffering from these reactions during their hospital stay.
Research covering cefoperazone use during pregnancy remains limited, even with decades of experience. The FDA places most cephalosporins in category B, but possible risks can’t get ruled out. Pregnant women should only receive this antibiotic if the benefits clearly take priority over the risks. The same logic fits for nursing mothers, as the drug can pass through breast milk.
Very young children and premature infants deserve special attention. Their kidneys and livers don’t yet handle medicines at full speed, and dosages require careful calculation to avoid toxicity. In practice, children tend to tolerate cephalosporins better than adults, yet doctors must still pay attention to weight and organ function.
Recognizing contraindications isn’t just a check mark on a chart; it makes all the difference between prompt recovery and life-threatening reactions. Medical teams need to ask about allergies, look at the liver’s function, and talk with patients about recent alcohol use. Pharmacists add another layer, checking dosing and flagging drug interactions before harm occurs.
In the end, it’s about reading the full story—not just the label. By paying attention to these red flags, we avoid dangerous mistakes and use powerful medicines like cefoperazone sodium where they can do their best work.
I remember flipping through medication leaflets in hospitals, hunting for an answer that felt right. The clinical language never gave a straight answer, especially when it came to antibiotics and pregnancy or nursing. Cefoperazone Sodium falls into that group of drugs with more questions than easy answers. It’s a powerful cephalosporin antibiotic, sometimes given when common options stop working, or infections turn stubborn in pregnant people.
Not every antibiotic has been tested on people who are pregnant or breastfeeding, and that’s true for cefoperazone. The research runs thin—rats and rabbits have been given high doses in labs, and they didn’t grow abnormal babies, but humans are another story entirely. That creates a gap. Health authorities like the FDA put cefoperazone in a category that basically means “only use if there’s no better choice.” So if penicillin or another safer antibiotic could do the trick, that’s the go-to.
I’ve seen it play out: caregivers weigh the real risk of an untreated infection, which can seriously threaten a pregnancy, against the shadowy possible risk of a drug’s side effects. In severe infections—kidney or blood infections, say—the stakes run high. Untreated infections pose real threats both to the pregnant person and the fetus. In these moments, doctors might rely on cefoperazone if the likely benefits win out over the uncertain risks.
Questions shift once the baby is born and breastfeeding starts. Small studies show only trace amounts of cefoperazone pass into breast milk. Babies haven’t suffered obvious side effects from this transfer. Still, that lack of evidence—not evidence of safety—guides recommendations. Some nurses suggest timing breastfeeding to avoid peak drug levels, or even switching to formula temporarily. That call depends on many factors: the age and health of the baby, the urgency of the illness, and what alternative drugs might work.
Tough decisions often come with incomplete data. That’s where a provider’s experience matters. Talking through options with an OB-GYN or infectious disease specialist can give a clearer view of choices. Those conversations matter. Honest answers help parents feel seen and take some stress out of a heavy moment. If another antibiotic does the job, most experts favor skipping cefoperazone. If not, using the shortest course at the lowest effective dose makes sense. Watching for side effects—diarrhea, thrush, allergic reactions, or liver issues—acts as another safety net.
A world with more research on antibiotics and childbearing would give families real answers. Right now, options feel limited by thin research and the unknowns that come along with it. Pregnant and nursing families deserve drugs that aren’t just “probably fine,” but proven safe. Until then, careful conversations and shared responsibility between patients and their healthcare teams remain essential. Fact-based, open guidance helps everyone balance hope, risk, and healing.
| Names | |
| Preferred IUPAC name | Sodium (6R,7R)-7-[(2R)-2-(4-ethyl-2,3-dioxopiperazin-1-yl)-2-(1H-tetrazol-1-yl)acetamido]-3-(1-methyltetrazol-5-ylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
| Other names |
Cefoperazone Cefoperazone sodium salt Cefoperazone Na |
| Pronunciation | /ˌsɛf.oʊˈpɛrəˌzoʊn ˈsoʊdi.əm/ |
| Identifiers | |
| CAS Number | 62893-20-3 |
| Beilstein Reference | 3534956 |
| ChEBI | CHEBI:3527 |
| ChEMBL | CHEMBL2105933 |
| ChemSpider | 22235 |
| DrugBank | DB01329 |
| ECHA InfoCard | ECHA InfoCard: 100000722592 |
| EC Number | 613-091-2 |
| Gmelin Reference | 1047008 |
| KEGG | D00261 |
| MeSH | D000900 |
| PubChem CID | 656770 |
| RTECS number | TT1112000 |
| UNII | NJ2G4205DI |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C25H26N9NaO8S2 |
| Molar mass | 667.563 g/mol |
| Appearance | White to off-white crystalline powder |
| Odor | Odorless |
| Density | Density: 1.74 g/cm³ |
| Solubility in water | Very soluble in water |
| log P | -2.3 |
| Acidity (pKa) | 2.7 |
| Basicity (pKb) | 11.38 |
| Magnetic susceptibility (χ) | -54.0×10⁻⁶ cm³/mol |
| Dipole moment | 1.57 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | Std molar entropy (S⦵298) of Cefoperazone Sodium: 397.8 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01DD12 |
| Hazards | |
| Main hazards | May cause allergic skin reaction; may cause respiratory irritation |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: Harmful if swallowed. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. |
| Precautionary statements | Keep container tightly closed. Store in a dry place. Store at room temperature. Avoid breathing dust. Wash thoroughly after handling. |
| Lethal dose or concentration | LD₅₀ (mouse, IV): 5600 mg/kg |
| LD50 (median dose) | LD50 (median dose): Mouse (intravenous): 5,000 mg/kg |
| PEL (Permissible) | PEL (Permissible exposure limit) for Cefoperazone Sodium: Not established |
| REL (Recommended) | 2 g/vial |
| IDLH (Immediate danger) | Not listed. |
| Related compounds | |
| Related compounds |
Cefoperazone Cefoperazone sulbactam Cefotaxime Ceftazidime Ceftriaxone Cefepime Cefazolin Cefuroxime |
